Inhibrx Biosciences, Inc.
Institutional Ownership & Holdings Analysis
About
inhibrx-biosciences is a publicly traded company tracked by institutional investors. This page displays information about the institutional ownership of the company's shares, showing which investment funds and asset managers hold positions in the company.
Top Institutional Holders
# | Institution | Value |
---|---|---|
1 | VIKING GLOBAL INVESTORS LP(2025-03-31) | $25.0M |
2 | Sanofi(2025-03-31) | $16.2M |
3 | PERCEPTIVE ADVISORS LLC(2025-03-31) | $14.9M |
4 | HighTower Advisors, LLC(2025-03-31) | $12.2M |
5 | BlackRock, Inc.(2025-03-31) | $11.6M |
6 | Sofinnova Investments, Inc.(2025-03-31) | $9.8M |
7 | Walleye Capital LLC(2024-12-31) | $8.9M |
8 | VANGUARD GROUP INC(2025-03-31) | $8.2M |
9 | PFM Health Sciences, LP(2025-03-31) | $6.1M |
10 | Woodline Partners LP(2025-03-31) | $5.0M |
11 | Slotnik Capital, LLC(2025-03-31) | $4.0M |
12 | GEODE CAPITAL MANAGEMENT, LLC(2025-03-31) | $3.6M |
13 | MILLENNIUM MANAGEMENT LLC(2025-03-31) | $3.6M |
14 | Castalian Partners, LLC(2024-12-31) | $2.9M |
15 | Caption Management, LLC(2025-03-31) | $2.8M |
16 | ACADIAN ASSET MANAGEMENT LLC(2025-03-31) | $2.7M |
17 | STATE STREET CORP(2025-03-31) | $2.4M |
18 | KENNEDY CAPITAL MANAGEMENT LLC(2025-03-31) | $2.3M |
19 | Schonfeld Strategic Advisors LLC(2025-03-31) | $2.0M |
20 | ArrowMark Colorado Holdings LLC(2025-03-31) | $2.0M |
As of 2025-03-31
Value:$25.0M
#2Sanofi
As of 2025-03-31
Value:$16.2M
As of 2025-03-31
Value:$14.9M
As of 2025-03-31
Value:$12.2M
As of 2025-03-31
Value:$11.6M
As of 2025-03-31
Value:$9.8M
As of 2024-12-31
Value:$8.9M
As of 2025-03-31
Value:$8.2M
As of 2025-03-31
Value:$6.1M
As of 2025-03-31
Value:$5.0M
As of 2025-03-31
Value:$4.0M
As of 2025-03-31
Value:$3.6M
As of 2025-03-31
Value:$3.6M
As of 2024-12-31
Value:$2.9M
As of 2025-03-31
Value:$2.8M
As of 2025-03-31
Value:$2.7M
As of 2025-03-31
Value:$2.4M
As of 2025-03-31
Value:$2.3M
As of 2025-03-31
Value:$2.0M
As of 2025-03-31
Value:$2.0M
Total Institutional Holders:113
Top 10 Holders Own:71.1%